Acquisition Will Further Enhance AnaBios' Human Tissue & Cells Portfolio, Help Scientists Expedite Drug Discovery & Further Understanding of Cell Biology
JACKSONVILLE, Fla., April 4, 2023 (Newswire.com)
–
CE Broker, a leader in healthcare compliance and continuing education (“CE”) management software, has…
After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.